Percutaneous Coronary Intervention in Native Arteries Versus Bypass Grafts in Prior Coronary Artery Bypass Grafting Patients A Report From the National Cardiovascular Data Registry by Brilakis, Emmanouil S. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 4 , N O . 8 , 2 0 1 1
© 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 1 . 0 3 . 0 1 8CLINICAL RESEARCH
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Coronary Artery Bypass Grafting Patients
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Objectives This study examined a large registry to determine the frequency, predictors, and out-
comes of native coronary artery versus bypass graft percutaneous coronary intervention (PCI) in pa-
tients with prior coronary artery bypass graft surgery (CABG).
Background The PCI target vessel and corresponding outcomes in prior CABG patients are poorly studied.
Methods We analyzed the frequency and factors associated with native versus bypass graft PCI in
prior CABG patients undergoing PCI between January 1, 2004, and June 30, 2009, in the National
Cardiovascular Data Registry (NCDR) CathPCI Registry. Generalized estimating equations logistic re-
gression modeling was used to generate independent variables associated with native versus bypass
graft PCI and in-hospital mortality.
Results During the study period, PCI in prior CABG patients represented 17.5% of the total PCI volume
(300,902 of 1,721,046). The PCI target was a native coronary artery in 62.5% and a bypass graft in 37.5%:
saphenous vein graft (SVG) (104,678 [34.9%]), arterial graft (7,517 [2.5%]), or both arterial graft and SVG
(718 [0.2%]). Compared with patients undergoing native coronary artery PCI, those undergoing bypass
graft PCI had higher-risk characteristics and more procedural complications. On multivariable analysis,
several parameters (including graft stenosis and longer interval from CABG) were associated with per-
forming native coronary PCI, and bypass graft PCI was associated with higher in-hospital mortality (ad-
justed odds ratio: 1.22, 95% conﬁdence interval: 1.12 to 1.32).
Conclusions Most PCIs performed in prior CABG patients are done in native coronary artery lesions.
Compared with native coronary PCI, bypass graft PCI is independently associated with higher in-
hospital mortality. (J Am Coll Cardiol Intv 2011;4:844–50) © 2011 by the American College of
Cardiology Foundation
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845After coronary artery bypass graft surgery (CABG), bypass
graft failure often develops, especially several years post-surgery
(1). Since redo CABG carries higher risk than initial CABG,
CI is the most common revascularization procedure after
ABG (2). Although PCI in patients with prior CABG
arries higher procedural risk (3) and worse outcomes com-
ared with PCI in patients without prior CABG (4), there are
ew reports on the specific target vessel (i.e., native coronary
rtery vs. bypass graft) and outcomes of PCI in such patients
5–8). We used the National Cardiovascular Data Registry
NCDR) CathPCI Registry to evaluate the contemporary
atterns of PCI in prior CABG patients, to identify factors
ssociated with PCI in native coronary arteries versus bypass
rafts, and to examine their in-hospital clinical outcomes.
ethods
Patient population. The NCDR CathPCI Registry is an
initiative of the American College of Cardiology Foundation
and the Society for Cardiovascular Angiography and Interven-
tions. The registry receives data from over 1,000 participating
U.S. hospitals, and catalogs in-hospital stay data regarding
patient characteristics, clinical features, angiographic and
procedural details, and in-hospital outcomes for patients
undergoing diagnostic catheterizations and PCI. The Cath-
PCI Registry includes in-hospital data collected on patients
undergoing cardiac catheterization and PCI procedures.
This is a standard dataset with pre-specified definitions,
uniform data entry and transmission requirements, and
data quality checks. There is no core laboratory adjudi-
cation of the angiographic parameters. Details on the
data collection process and the variable definitions have
been published previously (9). For the purpose of this
study, we examined CathPCI Registry patients with prior
CABG undergoing stenting from January 1, 2004, through
June 30, 2009.
Statistical analysis. Continuous variables were presented as
medians and interquartile ranges. Categorical variables were
reported as percentages. The baseline characteristics, PCI
procedural findings, and in-hospital outcomes were compared
between patients who underwent PCI of a native coronary
artery versus a bypass graft. Comparisons between groups were
performed using Pearson chi-square tests for all categorical
variables and Wilcoxon tests for all continuous variables.
Multivariable logistic regression analyses were performed
to determine variables associated with PCI of a native
coronary artery among all prior CABG patients undergoing
PCI. The following parameters were entered into the
model: age, gender, Caucasian race, body mass index, prior
myocardial infarction, diabetes, glomerular filtration rate,
congestive heart failure, cardiogenic shock, presentation
with ST-segment elevation acute myocardial infarction,
transfer for primary PCI, thrombolytic administration, pres-
ence of graft stenosis 70%, multivessel disease, prior PCI, dre-procedure Thrombolysis In Myocardial Infarction (TIMI)
ow grade, presence of high-risk coronary lesions, extent of
ative coronary artery disease, previously treated lesion, lesion
ength, time interval from prior CABG, and year of PCI.
Similarly, multivariable logistic regression analyses were
erformed to determine whether bypass graft PCI was inde-
endently associated with in-hospital mortality. The following
arameters were entered in the model: age, Caucasian race,
ody mass index, glomerular filtration rate, New York Heart
ssociation functional class, dialysis, ST-segment elevation,
ardiogenic shock, prior congestive heart failure, prior valve
urgery, prior cerebrovascular disease, peripheral arterial dis-
ase, chronic lung disease, prior PCI, insertion of intra-aortic
alloon pump pre-PCI, ejection fraction, subacute thrombosis,
IMI flow grade pre-stenting, diabetes, lesion class, lesion
egment, PCI status, and gender (10). Because patients within
hospital are more likely to be treated in a similar way,
eneralized estimating equations models were used to adjust
or within-hospital correlation.
All tests were 2-sided, and a
 0.05 was considered statis-
ically significant. All analyses
ere performed using SAS soft-
are (version 9.2, SAS Institute,
ary, North Carolina) by the
uke Clinical Research Institute
Durham, North Carolina). The
uthors had full access to the
ata and take responsibility for
ts integrity. All authors have
ead and agree to the manuscript
s written.
esults
PCI target vessel in prior CABG
patients. During the study period, PCI in prior CABG
atients represented 17.5% of the total PCI volume
300,902 of 1,721,046). The PCI target vessel in prior
ABG patients was only a native coronary artery in 62.5%
nd at least 1 bypass graft in 37.5% (Fig. 1). Most of the
arget grafts were saphenous vein grafts (SVGs) (n 
04,678 [34.9%]), and less frequently arterial grafts (n 
,517 [2.5%]) or both arterial grafts and SVGs (n  718
0.2%]). The proportion of SVGs as PCI target vessels
ncreased after 5 years and even more so after 10 years from
ABG (Table 1). Overall, the PCI target vessel was a native
oronary artery in 61.6% in 2004, 61.1% in 2005, 62.6% in
006, 62.1% in 2007, 63.2% in 2008, and 63.5% in 2009.
Comparison of native coronary artery versus bypass graft PCI
patients. The patients’ baseline and treatment characteris-
ics are summarized in Tables 2 and 3. Compared with
atients undergoing native coronary artery PCI, those un-
Abbreviations
and Acronyms
CABG  coronary artery
bypass graft surgery
CI  confidence interval
CTO  chronic total
occlusion
NCDR  National
Cardiovascular Data Registry
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation (acute) myocardial
infarction
SVG  saphenous vein graft
TIMI  Thrombolysis In
Myocardial Infarctionergoing bypass graft PCI were more likely to be men and
a
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846to have higher risk characteristics, and presented more
commonly with an acute myocardial infarction. On multi-
variable analysis, several parameters (including the presence
of graft stenosis 70%, longer time from previous CABG,
lack of multivessel disease, lower baseline TIMI flow grade,
male gender, high-risk lesions, and diabetes) were associ-
ated with higher likelihood of graft versus native coronary
artery PCI (Table 4).
Outcomes. Compared with patients undergoing native cor-
onary artery PCI, patients undergoing bypass graft PCI
more frequently required intra-aortic balloon pump coun-
terpulsation, required longer fluoroscopy time and larger
amount of contrast, less frequently achieved TIMI flow
grade 3 post-stenting, were more likely to receive blood
transfusions, and had higher rates of post-procedural com-
plications and in-hospital mortality (Table 3). On multi-
variable analysis, treatment of a bypass graft was indepen-
dently associated with higher in-hospital mortality: adjusted
odds ratio for SVG was 1.20 (95% confidence interval [CI]:
1.10 to 1.30), p  0.001; for arterial grafts was 1.50 (95%
CI: 1.18 to 1.90), p  0.001; for both arterial graft and
SVGs was 1.28 (95% CI: 0.70 to 2.37), p  0.426; and for
Figure 1. Target Vessel in Patients With Prior CABG
Comparison of the percutaneous coronary intervention target vessel in
patients with prior coronary artery bypass graft surgery (CABG) surgery
during different time intervals from CABG. p  0.001. SVG  saphenous
vein graft.
Table 1. Target Vessel for PCI Among Patients Classified According to the
0–1 Yr Post CABG 1–5 Y
Native coronary artery PCI 14,189 (68.0) 45
SVG PCI 5,500 (26.4) 12
Arterial graft PCI 1,041 (5.0) 1
Arterial graft and SVG PCI 141 (0.7)
Values are n (%). *Data on the interval from CABG were missing from 3,976 patients.CABG coronary artery bypass graft surgery; PCI percutaneous coronary intervention; SVG saphenny bypass graft intervention was 1.22 (95% CI: 1.12 to
.32), p  0.001.
Treatment of chronic total occlusions. PCI to a chronic total
occlusion (CTO) in a native coronary was attempted in 16,376
of 300,902 (5.44%) patients. PCI was successful in 76.6% of
the procedures, and in-hospital mortality for this group of
patients was 3.4%. In prior CABG patients undergoing native
CTO PCI, in-hospital mortality was 8.4% in unsuccessful
procedures, 5.2% in partially successful procedures, and 2.6% in
successful procedures.
Discussion
Data from the CathPCI Registry demonstrate that: 1) most
PCIs performed in prior CABG patients are done in native
coronary arteries; 2) most bypass graft PCIs are done in
saphenous vein grafts; and 3) patients undergoing bypass
graft PCI have higher-risk clinical characteristics and higher
in-hospital mortality.
PCI target vessel in prior CABG patients. Our study demon-
strates that in prior CABG patients, most PCIs (62.5%) are
performed in native coronary arteries. Previous studies were
much smaller and have shown variable results: native coro-
nary artery PCI was performed in 56% of 142 patients
reported by Varghese et al. (7) versus 44% of 95 patients
reported by Chen et al. (11). Chen et al. first showed that
SVG PCI accounted for the majority of PCI after10 years
post-CABG, whereas Cole et al. (12) showed that SVG
PCI accounted for 43% of PCI among 1,123 diabetic
post-CABG patients undergoing PCI. In our study, the
most common PCI target vessel in prior CABG patients
was a native coronary artery both early and late post-
CABG, although SVG PCI constituted an increasing
proportion of PCI 5 years and even more so 10 years
from CABG. Apart from progressive SVG failure late
post-CABG, another explanation for this finding is that
progression of native coronary artery atherosclerosis may
render native coronary arteries progressively less likely to be
amenable to PCI.
Coronary computed tomography has been advocated as
an accurate method to measure bypass graft patency (13),
but it has significant limitations for determining native
coronary artery patency, especially in the presence of
val From CABG*
t CABG 5–10 Yrs Post CABG >10 Yrs Post CABG
6.5) 57,743 (66.1) 69,674 (53.7)
0.4) 27,397 (31.4) 57,413 (44.2)
.9) 2,000 (2.3) 2,434 (1.9)
.2) 158 (0.2) 277 (0.2)Inter
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,088 (7
,047 (2
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122 (0ous vein graft.
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847calcification (14). Based on our finding that most PCIs in
prior CABG patients are performed in native coronary
arteries, coronary computed tomography may have sig-
nificant limitations in assessing coronary anatomy and
guiding angiography and revascularization decisions in
these patients, who frequently have accelerated native
coronary atherosclerosis and calcification. Moreover,
complete native and graft angiography is important, even
when engagement of the native coronary artery and/or
grafts is challenging in the presence of proximal complete
occlusions and calcification (15).
Choice of target PCI vessel in prior CABG patients. Tradi-
ionally PCI of a native coronary artery is preferred to SVG
CI that supplies the same territory, if feasible, since
Table 2. Comparison of Baseline Patient Characteristics in CathPCI Regist
to the Treated Vessel
Variable
Native Only
(n  187,989)
SVGs
(n  104,6
Demographics
Age, yrs 68 (60–76) 70 (62–77
Male 72% 77%
White race 86% 88%
Comorbidities
Hypertension 86% 87%
Hyperlipidemia 88% 88%
Diabetes mellitus 43% 44%
Noninsulin dependent 26% 28%
Insulin dependent 17% 16%
Smoking
Current 16% 17%
Former 44% 45%
Prior MI 45% 48%
Prior PCI 42% 45%
Cerebrovascular disease 17% 20%
Peripheral arterial disease 19% 23%
History of renal failure 8% 9%
Chronic lung disease 18% 18%
Warfarin use 6% 6%
Body mass index, kg/m2 28.9 (25.7–32.9) 28.6 (25.5–3
Presentation
Symptoms
No angina 14% 11%
Atypical chest pain 7% 6%
Stable angina 21% 16%
ACS: unstable angina 42% 40%
ACS: NSTEMI 12% 20%
ACS: STEMI 4% 7%
Congestive heart failure 12% 14%
Cardiogenic shock 1.3% 1.8%
Days from CABG to PCI, median 2,859 (1,431–4,539) 3,949 (2,492–
Values are % or n (interquartile range).
ACS  acute coronary syndrome(s); MI  myocardial infarction; NSTEMI  non–ST-segment ele
abbreviations as in Table 1.VG PCI carries higher acute and long-term risk (7,16). (lthough the exact factors behind target vessel choice in
he CathPCI Registry are not available, the main factors
ssociated with PCI target vessel selection included: 1) the
everity of SVG disease (which progressively worsens with
onger interval from CABG); and 2) the severity of native
oronary artery disease. Native coronary artery PCI may be
referred with diffusely degenerated SVGs, whereas SVG PCI
ay be preferred in the presence of long, tortuous, and calcified
ative coronary artery lesions or in the presence of CTOs.
rug-eluting stents are less commonly used in SVGs com-
ared with native coronary arteries, as was recently reported
rom the CathPCI Registry (17).
Most of the bypass graft interventions in prior CABG
atients were performed in SVGs (93%), with much fewer
tients With Prior CABG Undergoing PCI Classified According
Arterial Grafts
(n  7,517)
SVGs and Arterial Grafts
(n  718) p Value
67 (58–75) 68 (59–75) 0.001
72% 73% 0.001
81% 85% 0.001
86% 89% 0.001
88% 88% 0.769
45% 50% 0.001
26% 29% 0.001
19% 21% 0.001
17% 16% 0.001
46% 46% 0.001
45% 43% 0.001
41% 41% 0.001
18% 19% 0.001
22% 25% 0.001
10% 11% 0.001
18% 18% 0.048
5% 5% 0.368
28.7 (25.5–32.7) 28.7 (25.5–32.7) 0.001
0.001
15% 12%
8% 7%
20% 19%
39% 40%
13% 19%
4% 3%
15% 17% 0.001
1.9% 2.0% 0.001
2,572 (941–4,395) 2,998 (602–4,672) 0.001
(acute) myocardial infarction; STEMI  ST-segment elevation (acute) myocardial infarction; otherry Pa
78)
)
2.4)
5,501)
vation7%) performed in arterial bypass grafts. This is consistent
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848with the lower failure rates of arterial grafts, especially left
internal mammary artery bypass grafts (1). However, arterial
grafts were more likely to develop lesions at the distal
anastomosis compared with SVGs (Table 3).
Impact of CTOs. Post-CABG patients in whom PCI of a
ative coronary artery CTO was attempted in the present
eries had a relatively good success rate (77%) but high
n-hospital mortality (3.4%). As has been demonstrated
ith any CTO intervention (18), patients in whom CTO
CI was successful had better outcomes compared with
hose in whom CTO PCI failed. The presence of a CTO
Table 3. Comparison of Lesion Characteristics, Treatments, and Immediate
Prior CABG Undergoing PCI Classified According to the Type of Vessel Tha
Variable
Native Only
(n  187,989)
SVGs
(n  104,6
Lesion characteristics
Restenotic lesion 6.7% 8.7%
Lesion location
Aortic anastomosis — 20.4%
Body — 62.2%
Distal anastomosis — 17.3%
Lesion length, mm 15 (10–20) 16 (12–22)
Treatment
Unfractionated heparin 48.0% 53.4%
Enoxaparin 14.0% 17.1%
Bivalirudin 47.2% 41.9%
Glycoprotein IIb/IIIa inhibitor 30.5% 39.1%
Multivessel PCI 18.9% 14.6%
Number of stents implanted 1 (1–2) 1 (1–2)
Drug-eluting stents 71.7% 61.2%
1 44.1% 37.0%
2 or more 27.6% 24.3%
Pre-procedure TIMI ﬂow grade
3 61.6% 51.2%
2 21.2% 24.2%
1 10.0% 13.0%
0 6.5% 10.8%
Post-procedure TIMI ﬂow grade
3 96.0% 94.3%
2 1.7% 2.5%
1 0.5% 0.9%
0 1.5% 2.1%
Intra-aortic balloon pump 1.3% 2.2%
Fluoroscopy time, min 15.0 (9.5–23.5) 16.0 (10.5–2
Contrast use, ml 210 (150–285) 205 (150–27
Outcomes
Transfusion 3.3% 4.3%
Vascular complications 0.65% 0.67%
Procedural complications 4.7% 6.6%
In-hospital mortality 0.9% 1.5%
Values are % or n (interquartile range).
TIMI Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.ay adversely affect outcomes in patients who develop an ocute coronary syndrome, as this may affect an even larger
yocardial area than the target vessel distribution (19).
reatment of a native coronary artery CTO has been
escribed for acutely thrombosed SVGs that could not be
ecanalized, but it can be a very challenging procedure
equiring specialized equipment and expertise (20,21).
Outcomes after SVG versus native coronary PCI. Patients
ndergoing bypass graft interventions (in either arterial
rafts or SVGs) had higher in-hospital mortality compared
ith patients who underwent native coronary artery inter-
entions. Several factors may contribute to these worse
edural Outcomes in the CathPCI Registry Patients With
Treated
Arterial Grafts
(n  7,517)
SVGs and Arterial Grafts
(n  718) p Value
9.0% 8.9% 0.001
0.001
18.5% 20.0%
41.3% 47.2%
40.2% 32.8%
13 (10–20) 14 (10–20) 0.001
51.6% 49.2% 0.001
12.9% 17.0% 0.001
43.2% 44.2% 0.001
29.9% 37.6% 0.001
14.2% 70.9% 0.001
1 (1–2) 2 (2–3) 0.001
69.0% 79.0% 0.001
43.0% 18.8% 0.001
26.0% 60.2% 0.001
0.001
56.4% 56.7%
23.1% 23.7%
11.5% 11.6%
8.2% 7.2%
0.001
94.3% 96.4%
2.3% 1.4%
0.9% 0.7%
2.2% 1.4%
2.6% 3.3% 0.001
17.3 (11.2–25.9) 22.6 (15.8–32.3) 0.001
225 (160–300) 270 (200–350) 0.001
4.9% 4.3% 0.001
1.07% 1.54% 0.001
6.3% 7.1% 0.001
1.6% 1.4% 0.001Proc
t Was
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3.8)
9)utcomes, such as the higher-risk profile of the bypass graft
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849PCI patients (Table 1), and the more complex lesion
morphology (Table 2). SVG interventions are known to
have higher risk for both acute complications, such as
no-reflow and for subsequent in-stent restenosis (22,23),
whereas PCI of arterial grafts can be complicated by long
distance to the target lesion and excessive tortuosity (24).
These findings agree with previous studies: Varghese et
al. (7) reported higher risk of no-reflow among SVG PCI
patients. In the APEX-MI (Assessment of Pexelizumab in
Acute Myocardial Infarction) trial prior CABG patients
who presented with ST-segment elevation (acute) myocar-
dial infarction (STEMI) underwent PCI of the infarct-
related artery, which was a bypass graft in 63 patients or a
native vessel in 55 patients. TIMI flow grade 3 was achieved
less often in bypass grafts (67% vs. 88%), and bypass graft
PCI patients had higher 90-day mortality (19% vs. 5.7%)
compared with native artery PCI patients (8). Similar
findings were seen in a study of 128 prior CABG patients
presenting with STEMI from the Mayo Clinic (5) and in a
study of 169 prior CABG patients with STEMI that were
included in the PAMI-2 (Primary Angioplasty in Myocar-
dial Infarction-2), Stent-PAMI-Pilot, Stent-PAMI, PAMI
No SOS (Primary Angioplasty in Myocardial Infarction No
Surgery-on-Site), and Local Med Pilot trials (6).
A novel finding of our study was that in-hospital mor-
tality after arterial graft PCI was similar to SVG PCI and
significantly higher than native coronary interventions. This
could have occurred because arterial graft failure may be a
sign of advanced atherosclerosis or because arterial graft
failure (usually left internal mammary artery to the left
anterior descending artery) can result in a large area of
ischemic myocardium.
Study limitations. Not all U.S. facilities that perform cardiac
atheterization and coronary PCI participate in the Cath-
CI Registry, and therefore, the results may not be represen-
Table 4. Variables Associated With Treatment of Nat
CathPCI Registry Patients With Prior CABG
Variable Odds Ratio
Graft stenosis 70% 0.11
Years from prior CABG (odds ratio for 1 yr) 0.92
Multivessel disease 2.30
Pre-procedure TIMI ﬂow grade 1.15
Male 0.82
High-risk lesion 0.64
Diabetes 0.93
Right coronary artery stenosis 70% 0.83
STEMI 0.75
Glomerular ﬁltration rate (odds ratio for 5 U) 1.01
Left main stenosis 50% 0.87
Only the 11 strongest predictors of the multivariable model are presen
CI confidence interval; other abbreviations as in Tables 1 and 3.ative of the entire U.S. stenting population, although theumber of participating sites is large. In the CathPCI Registry,
here is no core laboratory assessment of the patients’ angio-
rams and composite assessments of the coronary anatomy,
uch as the SYNTAX (Synergy Between PCI With Taxus and
ardiac Surgery) score, were not available. CathPCI Registry
ata are collected for in-hospital stay only; as such, differences
n long-term outcomes of patients who underwent PCI of
ative coronary artery or a bypass graft could not be assessed. It
s not known what drove the decision to intervene on a native
oronary artery versus a bypass graft; therefore, unmeasured
nknown variables could be responsible for some of the
ariability in in-hospital outcomes post-native coronary artery
r bypass graft PCI.
onclusions
Most PCIs performed in prior CABG patients are done in
native coronary artery lesions, although SVG PCI becomes
more prevalent with longer time intervals from CABG. Com-
pared with native coronary PCI, bypass graft PCI is indepen-
dently associated with higher in-hospital mortality.
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kis, North Texas Health Care System, the University of Texas
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esbrilakis@yahoo.com.
REFERENCES
1. Goldman S, Zadina K, Moritz T, et al. Long-term patency of
saphenous vein and left internal mammary artery grafts after coronary
artery bypass surgery: results from a Department of Veterans Affairs
Cooperative Study. J Am Coll Cardiol 2004;44:2149–56.
2. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention
versus repeat bypass surgery for patients with medically refractory myocardial
oronary Artery Lesion in
ower 95% CI Upper 95% CI Chi-Square p Value
0.11 0.12 4,628 0.001
0.92 0.93 3,743 0.001
2.19 2.42 1,151 0.001
1.13 1.16 332 0.001
0.81 0.84 282 0.001
0.61 0.68 233 0.001
0.92 0.94 168 0.001
0.80 0.85 162 0.001
0.72 0.79 137 0.001
1.01 1.02 115 0.001
0.85 0.89 114 0.001
this table.ive C
L
ted inischemia: AWESOME randomized trial and registry experience with post-
CABG patients. J Am Coll Cardiol 2002;40:1951–4.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 8 , 2 0 1 1
A U G U S T 2 0 1 1 : 8 4 4 – 5 0
Brilakis et al.
Native vs. Graft PCI in Prior CABG Patients
8503. Boatman DM, Saeed B, Varghese I, et al. Prior coronary artery bypass
graft surgery patients undergoing diagnostic coronary angiography have
multiple uncontrolled coronary artery disease risk factors and high risk
for cardiovascular events. Heart Vessels 2009;24:241–6.
4. Brilakis ES, de Lemos JA, Cannon CP, et al. Outcomes of patients
with acute coronary syndrome and previous coronary artery bypass
grafting (from the Pravastatin or Atorvastatin Evaluation and Infection
Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z]
trials). Am J Cardiol 2008;102:552–8.
5. Al Suwaidi J, Velianou JL, Berger PB, et al. Primary percutaneous
coronary interventions in patients with acute myocardial infarction and
prior coronary artery bypass grafting. Am Heart J 2001;142:452–9.
6. Nguyen TT, O’Neill WW, Grines CL, et al. One-year survival in
patients with acute myocardial infarction and a saphenous vein graft
culprit treated with primary angioplasty. Am J Cardiol 2003;91:
1250–4.
7. Varghese I, Samuel J, Banerjee S, Brilakis ES. Comparison of percu-
taneous coronary intervention in native coronary arteries vs. bypass
grafts in patients with prior coronary artery bypass graft surgery.
Cardiovasc Revasc Med 2009;10:103–9.
8. Welsh RC, Granger CB, Westerhout CM, et al. Prior coronary artery
bypass graft patients with ST-segment elevation myocardial infarction
treated with primary percutaneous coronary intervention. J Am Coll
Cardiol Intv 2010;3:343–51.
9. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS,
Williams JF. The American College of Cardiology-National Cardio-
vascular Data Registry (ACC-NCDR): building a national clinical data
repository. J Am Coll Cardiol 2001;37:2240–5.
10. Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk
prediction for percutaneous coronary intervention: results from 588,398
procedures in the National Cardiovascular Data Registry. J Am Coll
Cardiol 2010;55:1923–32.
11. Chen L, Théroux P, Lespérance J, Shabani F, Thibault B, De Guise P.
Angiographic features of vein grafts versus ungrafted coronary arteries
in patients with unstable angina and previous bypass surgery. J Am Coll
Cardiol 1996;28:1493–9.
12. Cole JH, Jones EL, Craver JM, et al. Outcomes of repeat revascular-
ization in diabetic patients with prior coronary surgery. J Am Coll
Cardiol 2002;40:1968–75.
13. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary
artery imaging: magnetic resonance angiography and multidetector
computed tomography angiography: a scientific statement from the
American Heart Association Committee on Cardiovascular Imaging
and Intervention of the Council on Cardiovascular Radiology andIntervention, and the Councils on Clinical Cardiology and
Cardiovascular Disease in the Young. Circulation 2008;118:586–606.
14. Malagutti P, Nieman K, Meijboom WB, et al. Use of 64-slice CT in
symptomatic patients after coronary bypass surgery: evaluation of grafts
and coronary arteries. Eur Heart J 2007;28:1879–85.
15. Varghese I, Boatman DM, Peters CT, et al. Impact on contrast,
fluoroscopy, and catheter utilization from knowing the coronary artery
bypass graft anatomy before diagnostic coronary angiography. Am J
Cardiol 2008;101:1729–32.
16. Keeley EC, Velez CA, O’Neill WW, Safian RD. Long-term clinical
outcome and predictors of major adverse cardiac events after percuta-
neous interventions on saphenous vein grafts. J Am Coll Cardiol
2001;38:659–65.
17. Brilakis ES, Wang TY, Rao SV, et al. Frequency and predictors of
drug-eluting stent use in saphenous vein bypass graft percutaneous
coronary interventions: a report from the American College of Cardi-
ology National Cardiovascular Data CathPCI Registry. J Am Coll
Cardiol Intv 2010;3:1068–73.
18. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic
total occlusions: a systematic review and meta-analysis. Am Heart J
2010;160:179–87.
19. van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivessel
coronary disease on long-term mortality in patients with ST-elevation
myocardial infarction is due to the presence of a chronic total occlusion.
Am J Cardiol 2006;98:1165–9.
20. Brilakis ES, Banerjee S, Lombardi WL. Retrograde recanalization of
native coronary artery chronic occlusions via acutely occluded vein
grafts. Catheter Cardiovasc Interv 2010;75:109–13.
21. Abdel-Karim AR, Banerjee S, Brilakis ES. Percutaneous intervention
of acutely occluded saphenous vein grafts: contemporary techniques
and outcomes. J Invasive Cardiol 2010;22:253–7.
22. Banerjee S, Brilakis ES. Embolic protection during saphenous vein
graft interventions. J Invasive Cardiol 2009;21:415–7.
23. Brilakis ES, Saeed B, Banerjee S. Drug-eluting stents in saphenous
vein graft interventions: a systematic review. EuroIntervention 2010;5:
722–30.
24. Lichtenwalter C, Banerjee S, Brilakis ES. Dual guide catheter tech-
nique for treating native coronary artery lesions through tortuous
internal mammary grafts: separating equipment delivery from target
lesion visualization. J Invasive Cardiol 2010;22:E78–81.
Key Words: bypass graft  coronary bypass graft surgery 
percutaneous coronary intervention.
